TB-500 matches diffuse, systemic, or multi-site presentations where local injection cannot reach the full extent of the problem
That approval does not extend to general fat-loss use, off-label protocols, or any use outside the approved patient population and clinical oversight
Clinical signs of B12 deficiency include nausea, vomiting, loss of appetite, poor absorption of food (malabsorption syndrome), constipation, gas, weight loss, fatigue, lethargy, abdominal pain, and diarrhea
Most bioactive peptides are rapidly degraded by gastric acid and proteolytic enzymes, but researchers have found that BPC-157 resists this degradation
Below GLP-1s, below approved oral pharmacotherapy, below surgery for appropriate candidates and beside, not instead of, diet and exercise